Internal Workshop: NGS and biomarker data
Mon, 23 May
|Jónas Einarsson Auditorium
This is a closed meeting for CONNECT Partners and members of all CONNECT Working Groups to join.
Time & Location
23 May 2022, 13:00 – 14:30 CEST
Jónas Einarsson Auditorium, Ullernchausseen 64-66, 0379 Oslo, Norway
About the event
Welcome to the CONNECT Workshop: “NGS and biomarker data: how to build a system meeting the current and future needs of the different stakeholders?”
Host: CONNECT Working Group 4. WG4 invites all CONNECT Partners and members of all Working Groups to join. This will be a closed meeting for the CONNECT Consortium only.
Date: May 23rd, 2022, 13:00h - 14:30h plus networking afterwards and the opportunity to join the WG1 hosted seminar “Digital Pathology and AI” from 15:00h (same venue)
Venue: Jonas Einarsson Auditorium, Oslo Cancer Cluster Innovation Park, 1st Floor, Ullernchausseen 64 – 66. Link to join digitally will be added and shared beforehand.
AGENDA (Workshop will be in NORWEGIAN!)
13:00 – 13:05 Welcome and Introduction
WG Leads CONNECT WG 4
13:05 – 13:20 Storage, use and access of NGS Data in InPreD and IMPRESS
Representatives from InPreD
13:20 – 13:50 National PM Initiatives: a “geography lesson” introducing the landscape, processes, and international collaboration
- Developing the concept for the National Genome Center
Torunn Berge, Helse Sør-Øst RHF and Trine Rounge, Cancer Registry of Norway
- Sharing genomic data in Norway and in the European 1+ million genomes – ethical and legal aspects
Grethe Foss, Norwegian Directorate of Health
13:50 – 14:00 Industry Partner Perspective and INSPIRE-BIO proposal
Gry Festervoll and CONNECT Industry Partners
14:00 – 14:30 Discussion & Idea exchange
- How to build a system that will meet the future needs of the various stakeholders (patients, clinicians, National Tumor Board, regulators, payors, and Industry)?
- Can an INSPIRE-BIO like project be a relevant pilot? How should such a pilot look like? Which questions should be addressed to generate valuable insights and learning for Genome Center and Cancer Registry´s future set-up?